Correction to ‘Multiple optimality criteria support Ornithoscelida’

por Parry, L. A., Baron, M. G., Vinther, J.
Publicado 2018

Measurement of the Coherent Neutron Scattering Length of (3)He

por Ketter, W., Heil, W., Badurek, G., Baron, M., Loidl, R., Rauch, H.
Publicado 2005

The dielectric response of phenothiazine-based glass-formers with different molecular complexity

por Rams-Baron, M., Jędrzejowska, A., Jurkiewicz, K., Matussek, M., Musiał, M., Paluch, M.
Publicado 2021

Dugbe virus ovarian tumour domain interferes with ubiquitin/ISG15-regulated innate immune cell signalling

por Bakshi, S., Holzer, B., Bridgen, A., McMullan, G., Quinn, D. G., Baron, M. D.
Publicado 2013

Analysis of the antioxidant response of Nicotiana benthamiana to infection with two strains of Pepper mild mottle virus

por Hakmaoui, A., Pérez-Bueno, M. L., García-Fontana, B., Camejo, D., Jiménez, A., Sevilla, F., Barón, M.
Publicado 2012

The Fe-FeSi phase diagram at Mercury’s core conditions

por Edmund, E., Morard, G., Baron, M. A., Rivoldini, A., Yokoo, S., Boccato, S., Hirose, K., Pakhomova, A., Antonangeli, D.
Publicado 2022

Cone and rod photoreceptor transplantation in models of the childhood retinopathy Leber congenital amaurosis using flow-sorted Crx-positive donor cells

por Lakowski, J., Baron, M., Bainbridge, J., Barber, A.C., Pearson, R.A., Ali, R.R., Sowden, J.C.
Publicado 2010

Experimental evidence of high pressure decoupling between charge transport and structural dynamics in a protic ionic glass-former

por Wojnarowska, Z., Rams-Baron, M., Knapik-Kowalczuk, J., Połatyńska, A., Pochylski, M., Gapinski, J., Patkowski, A., Wlodarczyk, P., Paluch, M.
Publicado 2017

How societal responses to COVID-19 could contribute to child neglect

por Bérubé, A., Clément, M.-È., Lafantaisie, V., LeBlanc, A., Baron, M., Picher, G., Turgeon, J., Ruiz-Casares, M., Lacharité, C.
Publicado 2021

OA05-03. Efficacy study of a T-cell-based DNA vaccine delivered by intradermal electrotransfer in macaques

por Dereuddre-Bosquet, N, Baron, M, Méderlé-Mangeot, I, Kaldma, K, Sikut, R, Männik, A, Stanescu, I, Ustav, M, Le Grand, R, Martinon, F
Publicado 2009

Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations

por Hoa, S., Hudson, M., Troyanov, Y., Proudman, S., Walker, J., Stevens, W., Nikpour, M., Assassi, S., Mayes, M.D., Wang, M., Baron, M., Fritzler, M.J.
Publicado 2016

Phase II study of UFT and oxaliplatin in first-line treatment of advanced colorectal cancer

por Feliu, J, Vicent, J M, García-Girón, C, Constela, M, Fonseca, E, Aparicio, J, Lomas, M, Antón-Aparicio, L, Dorta, F J, Gonzalez-Baron, M
Publicado 2004

Cytosolic phospholipase A2α gene silencing in monocytes alters development of Th1 responses and reduces autoimmune arthritis

por Courties, G, Presumey, J, Baron, M, Escriou, V, Van Lent, P, Scherman, D, Cantagrel, A, Van den Berg, W, Jorgensen, C, Davignon, J-L, Apparailly, F
Publicado 2010

Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II study

por Van Cutsem, E, Dirix, L, Van Laethem, J-L, Van Belle, S, Borner, M, Gonzalez Baron, M, Roth, A, Morant, R, Joosens, E, Gruia, G, Sibaud, D, Bleiberg, H
Publicado 2005

Phase II study of capecitabine in combination with paclitaxel in patients with anthracycline-pretreated advanced/metastatic breast cancer

por Batista, N, Perez-Manga, G, Constenla, M, Ruiz, A, Carabantes, F, Castellanos, J, Gonzalez Barón, M, Villman, K, Söderberg, M, Ahlgren, J, Casinello, J, Regueiro, P, Murias, A
Publicado 2004

Phase II randomised trial of raltitrexed–oxaliplatin vs raltitrexed–irinotecan as first-line treatment in advanced colorectal cancer

por Feliu, J, Castañón, C, Salud, A, Mel, J R, Escudero, P, Pelegrín, A, López-Gómez, L, Ruiz, M, González, E, Juárez, F, Lizón, J, Castro, J, González-Barón, M
Publicado 2005

XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer

por Feliu, J, Salud, A, Escudero, P, Lopez-Gómez, L, Bolaños, M, Galán, A, Vicent, J-M, Yubero, A, Losa, F, De Castro, J, de Mon, M Á, Casado, E, González-Barón, M
Publicado 2006

Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer

por Feliu, J, Safont, M J, Salud, A, Losa, F, García-Girón, C, Bosch, C, Escudero, P, López, R, Madroñal, C, Bolaños, M, Gil, M, Llombart, A, Castro-Carpeño, J, González-Barón, M
Publicado 2010

Development and Testing of a Field Diagnostic Assay for Peste des Petits Ruminants Virus

por Baron, J, Fishbourne, E, Couacy-Hyman, E, Abubakar, M, Jones, B A, Frost, L, Herbert, R, Chibssa, T R, van't Klooster, G, Afzal, M, Ayebazibwe, C, Toye, P, Bashiruddin, J, Baron, M D
Publicado 2014

Irinotecan plus raltitrexed as first-line treatment in advanced colorectal cancer: a phase II study

por Feliu, J, Salud, A, Escudero, P, López-Gómez, L, Pericay, C, Castañón, C, de Tejada, M R López, Rodríguez-García, J M, Martínez, M P, Martín, M Sanz, Sánchez, J J, Barón, M González
Publicado 2004